The role of pharmacogenomics in adverse drug reactions

Abstract excerpt

INTRODUCTION: Adverse drug reactions (ADRs) are a major health concern worldwide. There are multiple causes of ADRs, some of which are preventable. Pharmacogenomics accounts for ≈80% variability in drug efficacy and safety. Over 400 genes are clinically relevant in drug metabolism, and ≈200 pharmagenes are associated with ADRs. The condition of extensive metabolizer in the Caucasian population is lower than 20%,...

Topics

Share this publication in a Topic to start or enrich a Post.

• Share to Drug-Induced Adverse Reactions
• Share to HIV/AIDS drug development and treatment
• Share to Pharmacogenetics and Drug Metabolism